Cargando…
l-Thyroxine in an Oral Liquid or Softgel Formulation Ensures More Normal Serum Levels of Free T4 in Patients with Central Hypothyroidism
CONTEXT: l-Thyroxine (l-T4) therapy of central hypothyroidism (CH) is guided by measurements of serum free thyroxine (FT4), which should be above the midnormal range value (MNRV). In some countries, novel formulations of oral l-T4 (liquid or softgel) are available further to the classic tablets. The...
Autores principales: | Benvenga, Salvatore, Capodicasa, Giovanni, Perelli, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701926/ https://www.ncbi.nlm.nih.gov/pubmed/29209276 http://dx.doi.org/10.3389/fendo.2017.00321 |
Ejemplares similares
-
Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients
por: Benvenga, Salvatore
Publicado: (2019) -
Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018) -
Daily requirement of softgel thyroxine is independent from gastric juice pH
por: Virili, Camilla, et al.
Publicado: (2022) -
Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis
por: Benvenga, Salvatore, et al.
Publicado: (2018) -
Comparison Among Two Liquid Formulations of L-thyroxine in the Treatment of Congenital Hypothyroidism in the First Month of Life: A Pilot Study
por: Tuli, Gerdi, et al.
Publicado: (2022)